Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for rare eye disease: drug trial targets vision loss

NCT ID NCT06388083

Ongoing Disease control Sponsor: Belite Bio, Inc Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a drug called tinlarebant in 60 people with Stargardt disease, a genetic condition that causes vision loss. The goal is to see if the drug can slow damage to the retina and preserve eyesight. Participants take the drug or a placebo, and researchers measure changes in eye health over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STARGARDT DISEASE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

severe early-childhood-onset retinal dystrophy Stargardt disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

STARGARDT DISEASE 1 STGD1

Contacts and locations

Locations

  • Belite Study Site

    Kobe, Japan

  • Belite Study Site

    Kyoto, Japan

  • Belite Study Site

    Tokyo, Japan

  • Belite Study Site - US01

    Boston, Massachusetts, 02115, United States

  • Belite Study Site - US02

    Durham, North Carolina, 27705, United States

  • Belite Study Site - US03

    Dallas, Texas, 75231, United States

  • Belite Study Site - US04

    Rochester, Minnesota, 55905, United States

  • Belite Study Site - US05

    La Jolla, California, 92093, United States

  • Belite Study Site - US06

    Miami, Florida, 33136, United States

  • Belite Study Site - US07

    Philadelphia, Pennsylvania, 19107, United States

  • Belite Study Site - US08

    Phoenix, Arizona, 85020, United States

  • Belite Study Site - US09

    San Francisco, California, 94158, United States

  • Belite Study Site - US10

    Westbury, New York, 11590, United States

  • Belite Study Site - US11

    Edina, Minnesota, 55435, United States

  • Belite Study Site - US12

    The Woodlands, Texas, 77384, United States

  • Belite Study Site - US13

    Austin, Texas, 78705, United States

  • Belite Study Site - US14

    New York, New York, 10032, United States

  • UK01 Belite Study Site

    London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.